NDAQ:HUMA) Humacyte Provides Update on Commercial Launch and Pricing of Symvess(TM) (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma ...
Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback